Company Overview of Université de Lausanne
University of Lausanne is an educational institution.
Key Executives for Université de Lausanne
Université de Lausanne does not have any Key Executives recorded.
Université de Lausanne Key Developments
Medigene AG Announces Collaboration Agreement with University of Lausanne
Jan 25 16
Medigene AG announced a collaboration agreement with the University of Lausanne in order to establish a better and faster method for selecting tumour-specific T cells characterised by expression of suitable T cell receptors (TCRs) for Medigene's expanding TCR library. The agreement provides Medigene access to the NTAmer technology that has been established by TCMetrix, a spin-off company of the Ludwig Institute for Cancer Research in Lausanne, and further developed in collaboration with leading scientists of the University of Lausanne. Financial terms of the agreement were not disclosed. Within the framework of the cooperation, scientists of the Department of Oncology of the University of Lausanne will perform kinetic dissociation analyses on human T cells using the innovative NTAmer technology. This technology measures cell-surface monomeric TCR-peptide-MHC dissociation rates of TCR candidates, which will allow Medigene to select tumour-specific T cells with an optimal functional avidity for different cancer cell types. The tailor-made NTAmer reagents are patented and will be provided by TCMetrix Ltd.
MRC Technology Collaborates with University of Lausanne for Lymphoma Treatment
Sep 28 15
MRC Technology is collaborating with the University of Lausanne. The collaboration is aimed at finding new drug treatments for diffuse large B cell lymphoma, the most common type of non-Hodgkin lymphoma.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries